Boill Healthcare Holdings' high P/S ratio is backed by its robust revenue growth over the past three years, outperforming the industry outlook. Investors anticipate further revenue growth, bolstering the high P/S ratio. The share price will remain strong unless recent medium-term conditions alter.
Despite superior medium-term revenue growth, the company's P/S ratio aligns with the industry, indicating potential future revenue fluctuations. The recent revenue decline, despite strong growth over the past three years, may be causing investor concern, pressuring the P/S ratio.
保集健康股票讨论区
暂无评论